These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Should all patients with ureteric colic be admitted? Morris SB, Hampson SJ, Gordon EM, Shearer RJ, Woodhouse CR. Ann R Coll Surg Engl; 1995 Nov; 77(6):450-2. PubMed ID: 8540666 [Abstract] [Full Text] [Related]
7. Double-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic. Chaudhary A, Gupta RL. J Indian Med Assoc; 1998 Nov; 96(11):359-60. PubMed ID: 10218327 [No Abstract] [Full Text] [Related]
8. Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic. Chaudhary A, Gupta RL. J Indian Med Assoc; 1999 Jun; 97(6):244-5. PubMed ID: 10645700 [Abstract] [Full Text] [Related]